This article has been corrected to list all of the genes targeted by the assay. The previous version noted only one of them.
NEW YORK (GenomeWeb) – Bioinformatics software firm Omixon today announced a licensing deal with the Children's Hospital of Philadelphia to commercialize a new next-generation sequencing-based HLA genotyping assay for use on Illumina's MiSeq instrument.